LiPlasome Pipeline

LiPlasome Pharmas most developed program is LiPlaCis® in clinical phase I trial. Further to this one preclinical programme is under development with Oxaliplatin as the active anti cancer agents. Several opportunities with different active anti cancer drugs can be persued.